News tagged with effect

FDA approves first drug for rare form of rickets

(HealthDay)—Ultragenyx Pharmaceutical Inc.'s Crysvita (burosumab-twza) has been approved by the U.S. Food and Drug Administration to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH).

Apr 23, 2018
popularity4 comments 0

How can medical marijuana benefit older adults?

Managing symptoms such as pain, nausea, and psychiatric illness can be challenging as people age. A new Journal of the American Geriatrics Society review highlights what's currently known about the indications and risks of ...

Apr 19, 2018
popularity2 comments 0

Subscribe to rss feed